WO2004063795A1 - 安全性の高いシリコーン含有眼用レンズ材料およびその製造方法 - Google Patents
安全性の高いシリコーン含有眼用レンズ材料およびその製造方法 Download PDFInfo
- Publication number
- WO2004063795A1 WO2004063795A1 PCT/JP2004/000071 JP2004000071W WO2004063795A1 WO 2004063795 A1 WO2004063795 A1 WO 2004063795A1 JP 2004000071 W JP2004000071 W JP 2004000071W WO 2004063795 A1 WO2004063795 A1 WO 2004063795A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ophthalmic lens
- lens material
- material according
- pyrrolidone
- meth
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
- C08F290/06—Polymers provided for in subclass C08G
- C08F290/068—Polysiloxanes
Definitions
- the present invention relates to an ophthalmic lens material and a method for producing the same. More specifically, the present invention relates to a contact lens, an intraocular lens, and a human cornea, which have high oxygen permeability, excellent flexibility, excellent surface water wettability, and excellent surface lubricity / ease.
- the present invention relates to an ophthalmic lens material which can be preferably used as a corneal onlay, a corneal inlay and the like, and a method for producing the same. Background art
- N-VP 1-Vinyl-2-pyrrolidone
- 1,3-MMP 1-methyl-3-methylene_2-pyrrolidone having a pyrrolidone skeleton
- 1,3-MMP has good compatibility with alkyl (meth) acrylamido-alkyl (meth) acrylate and is excellent in copolymerizability.
- Japanese Patent Publication No. Hei 6-82177 discloses a hydrogel having a high water content of 70% by weight or more obtained by copolymerizing 1,3-MMP and N-VP. These documents describe that use of 1,3-MMP as a main component can provide a hydrated gel with excellent flexibility. However, hydrated gels with a high water content can produce only contact lenses that have high flexibility but poor shape retention.
- the oxygen permeability of the contact lens made of a highly water-containing gel as described in these patent documents is significantly lower than the oxygen permeability of water, and the wearing state during continuous wearing or napping is poor. Considering this, it cannot be said that the necessary oxygen for the cornea can be permeated sufficiently.
- U.S. Pat. No. 5,486,579 describes that in order to improve the copolymerizability with N--VP, the polymerizability of other polymerizable components is increased.
- the structural design of the monomer is used to unify the base.
- Japanese Patent Application Laid-Open No. 6-214197 describes a contact lens composed of 1,3-MMP and a silicone-containing (meth) acrylate and / or a fluoroalkyl (meth) acrylate.
- silicone-containing (meth) acrylates and / or fluoroalkyl (meth) acrylates used as materials for oxygen-permeable contact lenses are used for the purpose of imparting shape retention and mechanical strength. Copolymerization is described.
- the contact lens material targeted here has a moisture content of about 37 to 58% by weight and an oxygen permeability coefficient of about 26 to 35, and is worn in continuous use or when napping. In consideration of this, it cannot be said that it has sufficient oxygen permeability.
- silicone-containing (meth) acrylates and copolymers containing Z or fluoroalkyl (meth) acrylate and a hydrophilic monomer as main components described in Japanese Patent Application Laid-Open No. Hei 6-214,197 have shape retention. Insufficient properties and mechanical strength.
- the compatibility of the components constituting the material is important.
- the material tends to undergo phase separation, and it is difficult to obtain a transparent material.
- Organic solvents are often used in such poorly compatible polymerizations.
- 32499123 discloses a method for producing a contact lens using an organic diluent in an amount of 5 to 60% by weight.
- a method is described in which a solvent is removed by evaporating the solvent at a specific temperature.
- the amount of organic solvent used is as large as several tens of percent, and when sufficient organic solvent is used to obtain a transparent material, the polymer is not freed by radical chain transfer to the organic solvent.
- the degree of polymerization tends to decrease, and a decrease in the strength of the material itself is inevitable.
- the amount of the monomer polyol dissolved from the material is increased. Furthermore, it is cumbersome and difficult to remove a large amount of organic solvent from the system, and it is not suitable for mass production.
- the present invention has been made in view of the above prior art, and has excellent oxygen permeability, surface water wettability, lubricity, and Z easiness, has low surface tackiness, and has excellent flexibility and rebound. It is an object of the present invention to provide an ophthalmic lens material having a property and a manufacturing method thereof. Furthermore, we will improve the low polymerizability seen in systems using N-VP as a hydrophilic component, establish a system that can reduce residual components in lens manufacturing, and suppress monomer leaching from final products. The aim was to provide a safe ophthalmic lens material. Disclosure of the invention
- an ophthalmic lens material having the above characteristics, a compound having an ethylenically unsaturated group and a polydimethylsiloxane structure through a specific urethane bond, and 1,3-MMP A pyrrolidone derivative in which the polymerizable group is a methylene group, for example, 1-alkyl-3-methylene1-2-pyrrolidone, monoalkyl-5-methylene-12-pyrrolidone, pentaalkyl-3-methylene1-2_
- the present inventors have found that an ophthalmic lens material containing pyrrolidone as an essential component has the above properties, and have completed the present invention.
- the present invention relates to (A) at least one compound having an ethylenically unsaturated group and a polydimethylsiloxane structure via a urethane bond and (B) at least one pyrrolidone derivative whose polymerizable group is a methylene group.
- the present invention also relates to a method for producing an ophthalmic lens material
- A urethane bond
- B hydrophilic monomer
- a mixed solution containing a photopolymerization initiator and Z or a thermal polymerization initiator and b) introducing the mixed solution into a mold
- the present invention relates to a method for producing an ophthalmic lens material containing: BEST MODE FOR CARRYING OUT THE INVENTION
- the ophthalmic lens material of the present invention comprises at least one compound (A) having an ethylenically unsaturated group and a polydimethylsiloxane structure via a urethane bond and at least one pyrrolidone derivative having a polymerizable group as a methylene group ( B).
- the compound (A) has an elastic bond called a urethane bond, reinforced without losing the flexibility and oxygen permeability of the material by the siloxane portion, and imparts elastic repulsion to eliminate brittleness. It is a component that imparts the property of improving mechanical strength. Further, since the compound (A) has a silicone chain in the molecular chain, it can impart high oxygen permeability to the product.
- the compound (A) has an ethylenically unsaturated group, which is a polymerizable group, at both ends of the molecule, and is copolymerized with other copolymerization components via such a polymerizable group. It has the excellent property of imparting not only a physical reinforcing effect by entanglement of molecules but also a chemical bonding (covalent bond) to the material. That is, the compound (A) acts as a polymer crosslinkable monomer.
- Compound (A) has the general formula (1):
- Y 21 is (meth) Akuriroiru group, vinyl group or Ariru group, Z 2 1 represents an oxygen atom or a direct bond, R 31 is a direct bond or a C 1 to 1 2 linear, branched or aromatic Which represents an alkylene group having a ring);
- a 2 is a general formula (3):
- Upsilon 22 is (meth) Akuriroiru group, vinyl group or Ariru group, Zeta 2 2 represents an oxygen atom or a direct bond, R 34 is a direct bond or a C 1 to 1 2 linear, branched or aromatic A group represented by the following formula (indicating an alkylene group having a ring) (provided that ⁇ 21 in the general formula (2) and ⁇ 22 in the general formula (3) may be the same or different);
- U 1 is a general formula (4):
- R 32 represents an alkylene group which have a straight-chain or
- S 1 and S 2 are each independently of the general formula (5):
- R 23 , R 24 , R 25 , R 26 , R 27 and R 28 are each independently an alkyl group having 1 to 6 carbon atoms, a fluorine-substituted alkyl group or a phenyl group, and K is An integer of 10 to 100, L is 0 or an integer of 1 to 90, and K + L is an integer of 10 to 100);
- U 2 is a general formula (6):
- R 37 and R 38 are each independently a linear or branched alkylene group having 1 to 6 carbon atoms; X 27 and X 28 are each independently an oxygen atom or an alkylenedalycol. group; E 24 is a saturated or unsaturated alicyclic aliphatic series divalent group Jiisoshiane Bok from selected from the group of fl cyclic and aromatic systems (provided that in this case, E 24 is X 27 and X 28 Which forms two urethane bonds between)
- U 3 is a general formula (7):
- R 33 is a linear or branched alkylene group having 1 to 6 carbon atoms
- X 22 and X 26 are each independently selected from a direct bond, an oxygen atom and an alkylene glycol group
- E 22 is one NHCO— group (where X 22 is an oxygen atom or an alkylene glycol group, X 26 is a direct bond, and E 22 forms a urethane bond with X 22 ), CO NH_ group (however, in this case, X 22 is a direct bond, X 26 is an oxygen atom or an alkylene alcohol group, and E 22 forms a urethane bond with X 26 ) or saturated or A divalent group derived from diisocyanate selected from the group consisting of unsaturated aliphatic, alicyclic and aromatic (where X 22 and X 26 are each independently an oxygen atom or an alkylene glycol group Wherein E 22 forms two urethane bonds between X 22 and X 26 );
- n 0 or an integer of 1 to 10]
- n 0 or an integer of 1 to 10]
- n is a polysiloxane macromonomer in which a polymerizable group represented by the formula is bonded to the siloxane main chain through one or more urethane bonds.
- a 1 is, as described above, a general formula (2):
- ⁇ 2 is a group represented by the general formula (3):
- Upsilon 21 and Upsilon 22 is each a polymerizable group, in that the hydrophilic monomer first and (D) can be readily copolymerized, Akuriroiru group is particularly preferred.
- Each of ⁇ 21 and ⁇ ⁇ 22 is an oxygen atom or a direct bond, preferably an oxygen atom.
- Each of R 31 and R 34 is a direct bond or an alkylene group having a straight, branched or aromatic ring having 1 to 12 carbon atoms, preferably an alkylene group having 2 to 4 carbon atoms.
- U 1 , U 2 and U 3 each represent a group containing a urethane bond in the molecular chain of the compound ( ⁇ ).
- E 21 and E 22 are, as described above, it Represents a CONH— group, an NHCO— group, or a divalent group derived from diisocyanate selected from the group consisting of saturated or unsaturated aliphatic, alicyclic and aromatic groups.
- the divalent group derived from diisocyanate selected from the group consisting of saturated or unsaturated aliphatic, alicyclic and aromatic groups includes, for example, ethylene diisocyanate, 1,3-diisocyanate Divalent groups derived from saturated aliphatic diisocyanates such as propane and hexamethylene diisocyanate; 1,2-diisocyanatocyclohexane; bis (4-isoisocyanatocyclohexyl) methane; Divalent groups derived from alicyclic diisocyanates such as isophorone diisocyanate; divalent groups derived from aromatic diisocyanates such as tolylene diisocyanate and 1,5-diisocyanate naphthalene; 2, 2 'Diisocyanate Divalent groups derived from unsaturated aliphatic diisocyanates such as getyl fumarate.
- saturated aliphatic diisocyanates such as propane and hexamethylene diisocyanate
- a divalent group derived from hexamethylenediisocyanate, a divalent group derived from tolylene diisocyanate, and isofhorondidisocyanate are relatively easy to obtain and easy to impart strength.
- Preferred is a divalent group derived from mono.
- E 21 is a divalent group derived from the above diisocyanate
- X 21 and X 25 are each independently selected from an oxygen atom and preferably an alkylene glycol group having 1 to 6 carbon atoms. is, E 21 forms two urethane bonds in between the X 21 and X 25.
- R 32 is ⁇ alkylene group having a linear or branched chain of from 1 to 6 carbon.
- E 24 is, as described above, represents a saturated or unsaturated aliphatic divalent group derived from Jiisoshianeto selected from the group consisting of alicyclic and aromatic systems.
- a divalent group derived from sophorone disocyanate is preferred.
- E 24 forms two urethane bonds in between the X 27 and X 28.
- X 27 and X 28 are each independently an oxygen atom or preferably an alkylene glycol group having 1 to 6 carbon atoms, and R 37 and R 38 are each independently a linear or branched chain having 1 to 6 carbon atoms. Is an alkylene group having
- R 33 is an Al Quillen group having a linear or branched chain of from 1 to 6 carbon. If it is E 22 gar NHCO- group, X 22 is oxygen atom or an alkylene glycol group, X 26 is a direct bond, E 22 is X 22 and wherein: the urethane bond represented in one NHCOO- To form Also, in the case of E 22 gar CONH- group, X 22 is a direct bond, X 2 6 is an oxygen atom or an alkylene glycol group, E 22 is X 26 and formula represented in one OCONH- To form a urethane bond.
- E 22 is a divalent group derived from the above diisocyanate
- X 22 and X 26 are each independently selected from an oxygen atom and preferably an alkylene glycol group having 1 to 6 carbon atoms. , E 22 forms two urethane bonds in between the X 22 and X 26.
- X 21 , X 25 , X 27 , X 28 , X 22, and preferably, alkylene glycol having 1 to 20 carbon atoms in X 26 is, for example, a general formula: (8):
- S 1 and S 2 are both groups represented by the general formula (5).
- R 23 , R 24 , R 25 , R 26 , R 27, and R 28 each independently represent an alkyl group having 1 to 6 carbon atoms or a fluorine-substituted alkyl group, as described above. Or a phenyl group.
- the compound (A) having such a fluorine-substituted alkyl group is used and the amount thereof is increased, the anti-lipid contamination of the obtained ophthalmic lens material tends to be improved.
- K is an integer of 10 to 100; L is 0 or an integer of 1 to 90; K + L is preferably an integer of 10 to 100, and more preferably 10 to 80.
- K + L is larger than 100, the molecular weight of compound (A) becomes large, the compatibility with the pyrrolidone derivative and other hydrophilic monomers becomes poor, and the compound (A) dissolves uniformly during compounding.
- the polymerization does not occur, the phase separation occurs during the polymerization, and the opacity tends to be exhibited, and a uniform and transparent ophthalmic lens material tends not to be obtained.If it is less than 10, the oxygen permeability of the obtained ophthalmic lens material is low. And tend to be less flexible.
- n is preferably 0 or an integer of 1 to 10. If n is greater than 10, the molecular weight of compound (A) will increase, and the compatibility with the pyrrolidone derivative and other hydrophilic monomers will be poor, and the compound (A) will not dissolve uniformly at the time of compounding or will not be polymerized. Occasionally, phase separation causes cloudiness, and there is a tendency that a uniform and transparent ophthalmic lens material cannot be obtained. n is more preferably 0 or an integer of 1 to 5.
- Compound (A) is represented by the general formula (9):
- Upsilon 21 in AA 2 is a (meth) Akuriroiru group, vinyl group or Ariru group.
- ⁇ 1 and ⁇ 2 are represented by the general formula (10):
- D is a hydrogen atom, a methyl group or a hydroxyl group
- Q is a direct bond or an oxygen atom
- n is 5 to 10,000.
- the polymer chain of the polymer composed of these units is branched even if it is linear.
- X may be bonded in a random shape or a block shape.
- 000) is a hydrophilic polymer-containing segment or a hydrophilic oligomer-containing segment represented by).
- the polymerizable group represented by) is bonded to the siloxane main chain through one or more urethane bonds. It is a polysiloxane mac mouth monomer.
- Compound (A) may further have a hydrophilic polymer structure. With this structure, the compatibility between the compound (A) and the hydrophilic monomer is improved, and the water wettability of a material composed of the compound (A) and the hydrophilic monomer can be improved.
- the structure of the hydrophilic polymer part is polyethylene glycol, polypropylene glycol, polybier alcohol, polybierpyrrolidone, poly (meth) acrylic acid, poly (meth) acrylate, poly (2-hydroxyethyl (meth) acrylate) ), Polytetrahydrofuran, polyoxetane, polyoxazoline, getylacrylamide, poly (2- Examples include one or more polymers obtained by polymerizing a zwitterionic group-containing monomer such as (rylcholine).
- the molecular weight of the hydrophilic polymer structure is from 100 to 1,000, 000, preferably from 1,000 to 500,000.
- compound (A) include, for example, compounds of the formula:
- At least one pyrrolidone derivative (B) in which the polymerizable group used in the present invention is a methylene group for example, 1_alkyl-3-methylene-2-pyrrolidone, 1_alkyl_5-methylene-1-pyrrolidone, 5-Alkyl-3-methylene-1-pyrrolidone is a component that imparts excellent flexibility and water wettability to ophthalmic lens materials, and further improves the feeling of wearing.
- N-pinylpyrrolidone which is a hydrophilic monomer, is used.
- At least one pyrrolidone derivative (B) in which the polymerizable group is a methylene group has high polymerizability, so that elution of unreacted monomers remaining in product materials can be suppressed.
- the amount of at least one pyrrolidone derivative (B) in which the polymerizable group with respect to all polymerizable components is a methylene group is increased, the surface water wettability and lubricity of the ophthalmic lens material are improved. Properties can be imparted.
- the amount of the at least one pyrrolidone derivative (B) in which the polymerizable group is a methylene group is preferably 5 to 60% by weight, more preferably 10 to 100% by weight, based on all polymerizable components. ⁇ 55% by weight. If the amount of the at least one pyrrolidone derivative (B) in which the polymerizable group is a methylene group is less than 5% by weight, the desired water wettability and surface lubricity cannot be achieved, and the material cannot be easily wetted. Water wettability on the surface tends to be poor. On the other hand, when the content exceeds 60% by weight, the oxygen permeability becomes dominant in the moisture content, and there is a tendency that sufficient oxygen cannot be supplied to the cornea when the wearing state during continuous wearing or napping is considered.
- the at least one pyrrolidone derivative (B) in which the polymerizable group is a methylene group used in the present invention includes 1-methyl-13-methylene-12-piperidone, 1-ethyl-13-methylene-12- Pyrrolidone, 1-methyl-5-methylene-12-pyrrolidone, 1-ethyl-5-methylene-12-pyrrolidone, 5-methyl-13-methylene-12-pyrrolidone, 5-ethyl-3-methylene-1-pyrrolidone, 1- _ ⁇ -propyl-1 3-methylene-1 2-pyrrolidone, 1- ⁇ -propyl-1 5-methylene-1 2-pyrrolidone, 1-i-propyl 3-methylene-1 2-pyrrolidone, 1-i-propyl-1 Examples include, but are not limited to, 5-methylene-12-pyrrolidone, 1-p-butyl-3-methylene-12-pyrrolidone, and 1-1-ptyl-3-methylene-12-pyrrolidone.
- At least these polymerizable groups are methylene groups.
- one of the pyrrolidone derivatives has high hydrophilicity, a material with excellent hydrophilicity can be obtained by using a small amount, and the production method is relatively easy, so that 1-methyl-3-methylene-1- Pyrrolidone, 1-methyl-15-methylene-12-pyrrolidone, 5-methyl-3-methylene-12-pyrrolidone are preferred.
- a silicone compound (C) other than the compound (A) is contained as an ophthalmic lens material in order to further improve the oxygen permeability of the obtained ophthalmic lens material and to impart flexibility.
- a silicone compound (C) other than the compound (A) is contained as an ophthalmic lens material in order to further improve the oxygen permeability of the obtained ophthalmic lens material and to impart flexibility.
- silicone compound (C) examples include a silicone-containing alkyl (meth) acrylate, a silicone-containing styrene derivative, and a silicone-containing fumaric acid diester. These can be used alone or in combination of two or more.
- ⁇ (meth) acrylate means “ ⁇ acrylate and Z or ⁇ ⁇ methacrylate”, and the same applies to other (meth) acrylate derivatives.
- Silicone-containing alkyl (meth) acrylates include, for example, Acrylate, methylilebis (trimethylsiloxy) silylpropyl (meth) acrylate, tris (trimethylsiloxy) silylpropyl (meth) acrylate, mono [methylbis (trimethylsiloxy) siloxy] bis (trimethylsiloxy) silylpropyl (meth) acrylic Tris, tris [methylbis (trimethylsiloxy) siloxy] silylpropyl (meth) acrylate, methylbis (trimethylsiloxy) silylpropylglyceryl (meth) acrylate, tris (trimethylsilyloxy) silylpropylglyceryl (meth) acrylyl — And mono [methylbis (trimethylsiloxy) siloxy] bis (trime Tylci mouth xy) silylpropyl glyceryl (meth) acrylate, trimethacrylate, trimethylsily
- silicone-containing styrene derivative for example, a compound represented by the general formula (12):
- silicone-containing styrene derivative represented by the general formula (12) examples include tris (trimethylsiloxy) silylstyrene, bis (trimethylsiloxy) methylsilylstyrene, (trimethylsiloxy) dimethylsilylstyrene, and tris (trimethylsilylstyrene).
- Siloxy Siloxydimethylsilylstyrene, [bis (trimethylsiloxy) methylsiloxy] dimethyl Silyl styrene, (trimethylsiloxy) dimethylsilyl styrene, heptamethyltrisiloxanyl styrene, nonamethyltetrasiloxanyl styrene, pentadecamethylhepxyl oxanyl styrene, heneicosamyldecasiloxanyl styrene, hepatocosamethyl Tridecasiloxanil
- Pentamethyldisiloxy) silylstyrene tris (trimethylsiloxy) siloxybis (trimethylsiloxy) silylstyrene, bis (heptamethyltricyclooxy) methylsilylstyrene, tris [methylbis (trimethylsiloxy) siloxy] silylstyrene, trimethylsiloxybis [ Tris (trimethylsilicyloxy) siloxy] silyl styrene, heptix (trimethylsilicone oxy) trisilyl styrene, nonamethyltetrasiloxydimethyl thimethylsiloxyl) Siloxy] silyl styrene, (tristrimethylsilicyl oxyhexamethyl) Tetrasiloxy [tris (trimethylsiloxy) siloxy] trimethylsiloxysilylstyrene, nonakis (trimethylsiloxy) tetrasilylstyrene,
- R 1 R 2 , R 3 , R 4 , R 5 and R 6 are each independently a methyl group or a formula:
- n and n each independently represent an integer of 1 to 3).
- Examples of the compound represented by the general formula (13) include bis (3- (trimethylsilyl) propyl fumarate, bis (3- (pentamethyldisiloxanyl) propyl) fumarate, and bis (3- (1,3,3 , 3-tetramethyl-11- (trimethylsilyl) oxy) disiloxanyl) propyl) fumarate, bis (tris (trimethylsiloxy) silylpropyl) fumarate and the like. These can be used alone or in combination of two or more.
- silicone-containing alkyl (meth) acrylates are preferred from the viewpoints of imparting flexibility of the material and copolymerizability of the compound (A) and the pyrrolidone derivative (B). From the viewpoint of imparting flexibility, tris (trimethylsiloxy) silylpropyl (meth) acrylate is more preferred.
- the amount used is preferably from 3 to 65% by weight, more preferably from 5 to 60% by weight, based on all polymerizable components. It is.
- the amount of the silicone-containing alkyl (meth) acrylate is less than 3% by weight, the obtained ophthalmic lens material tends to be brittle and inferior in flexibility with high elastic modulus.
- it exceeds 65% by weight the elasticity decreases, but the resilience of the material is inferior and the surface tackiness tends to increase.
- the amount used is preferably 1 to 30% by weight, more preferably 3 to 20% by weight, based on all polymerizable components. is there. If the amount of the silicone-containing styrene derivative is less than 1% by weight, the resulting ophthalmic lens material tends to be unable to sufficiently improve oxygen permeability and mechanical strength. On the other hand, if it exceeds 30% by weight, the flexibility of the obtained ophthalmic lens material tends to decrease.
- the amount of the silicone-containing fumaric acid diester used in the silicone compound (C) is preferably 1 to 50% by weight, more preferably 3 to 40% by weight, based on all polymerizable components. It is. When the amount of the silicone-containing fumaric acid diester used is less than 1% by weight, the oxygen permeability of the obtained ophthalmic lens material tends not to be sufficiently improved. On the other hand, if it exceeds 50% by weight, sufficient mechanical strength tends not to be obtained.
- the ophthalmic lens material of the present invention preferably contains N-substituted acrylamide (D).
- N-substituted acrylamide (D) as an ophthalmic lens material, it can act as a compatibilizer for the silicone component together with the pyrrolidone derivative (B) and produce a uniform transparent hydrogel having excellent transparency.
- Ophthalmic lens material obtained using pyrrolidone derivative (B) alone without N-substituted acrylamide (D) due to poor compatibility with silicone-containing components such as compound (A) and silicone compound (C) There is a tendency for transparency to decrease.
- silicone-containing components such as compound (A) and silicone compound (C)
- the compatibility with the silicone-containing component is improved, and the transparency of the obtained ophthalmic lens material is improved. Can be improved.
- N-substituted acrylamides (D) include N, N-dimethylacrylamide, N, N-getylacrylamide, N- (2-hydroxyethyl) Acrylamide, N-isopropylacrylamide, acryloyl morpholine and the like can be mentioned. Of these, N, N-dimethylacrylamide, N, N-getylacrylamide, and acryloylmorpholine are preferred because compatibility can be improved with a small amount.
- N-substituted acrylamide (D) when used, it is preferably 3 to 40% by weight, more preferably 5 to 35% by weight, based on the total polymerizable components. If the amount of N-substituted acrylamide (D) is less than 3% by weight, the polymerization system tends to become cloudy and the transparency of the ophthalmic lens material tends to decrease. On the other hand, when the content exceeds 40% by weight, the N-substituted acrylamide tends to easily take up lipids in tears due to amphipathicity and easily stain as an ophthalmic lens. At this time, if the use of the open mouth derivative (B) is reduced to further obtain a desired oxygen permeability, the water wettability and lubricity of the surface of the ophthalmic lens material tend to be impaired. .
- the ratio of the pyrrolidone derivative (B) to the N-substituted acrylamide (D) is preferably 40 Z because if the pyrrolidone derivative (B) is small, the surface water wettability and lubricity of the ophthalmic lens material may be impaired. 60 or more, more preferably 45 Z55 or more, and even more preferably 50 Z50 or more.
- the pyrrolidone derivative (B) is large, the polymerization system becomes cloudy and the ophthalmic lens material is transparent. In addition, the hardness of the material itself increases, which may adversely affect the feeling of wearing. Therefore, it is preferably 100 Z0 or less, more preferably 95-5 or less, and even more preferably 90/0 or less. 10 or less.
- the silicone compound (C) and the N-substituted acrylamide (D) are further added to the compound (A) and the pyridone derivative (B), which are essential components, as the ophthalmic lens material of the present invention.
- the percentage is as follows It is preferable to set as follows.
- the ratio of the sum of the compound (A) and the silicone compound (C) to the sum of the pyrrolidone derivative (B) and the N-substituted acrylamide (D) [ ⁇ (A) + (C) ⁇ / ⁇ (B) + ( D) ⁇ (weight ratio) means that if (B) + (D) is large, the oxygen permeability of the ophthalmic lens material depends on the water content, and it is impossible to obtain high oxygen permeability. Therefore, the ratio is preferably 30 to 70 or more, more preferably 35/65 or more, and further preferably 40/60 or more.
- the amount of (A) + (C) is large, the flexibility of the ophthalmic lens material is lost, and the material becomes hard and stiff and has a sticky surface, which adversely affects the feeling of wearing. It is preferably 70Z30 or less, more preferably 67/33 or less, and even more preferably 65/35 or less.
- the ratio of the compound (A) to the silicone compound (C) [(A) / (C) (weight ratio)] is such that when the silicone compound (C) is large, the surface of the ophthalmic lens material becomes noticeably sticky.
- the shape retention of the material is reduced, so that it is preferably at least 25Z 75, more preferably at least 27/73, even more preferably at least 30/70.
- the amount of the compound (A) is large, the flexibility of the ophthalmic lens material is lost, and the material becomes hard and brittle. Therefore, it is preferably 75/25 or less, more preferably 73Z27 or less, and further preferably 70/30 or less. It is as follows.
- a hydrophilic monomer (E) other than the N-substituted acrylamide (D), which is copolymerized with the pyrrolidone derivative (B), can be used.
- a hydrophilic monomer (E) as an ophthalmic lens material, the resulting ophthalmic lens material is given flexibility and surface water wettability, improving the feeling of wearing, and imparting lubricity / easiness of lubrication can do.
- hydrophilic monomer (E) examples include (meth) acrylamide; 2-hydroxyethyl (meth) acrylate, hydroxypropyl (meth) acrylate, and hydroxybutyl (meth) acrylate.
- Alkyl aminoalkyl (meth) acrylates such as 2-alkylaminoethyl (meth) acrylate and 2-butylaminoethyl (meth) acrylate; ethylene glycol mono (meth) acrylate, propylene glycol Alkylene glycol mono (meth) acrylates such as poly (meth) acrylate; polyethylene glycol mono (meth) acrylate and polyalkylene such as polypropylene glycol mono (meth) acrylate Ricol mono (meth) acrylate; ethylene glycol aryl ether; ethylene glycol biel ether; (meth) acrylic acid; aminostyrene; hydroxystyrene; vinyl acetate; glycidyl (meth) acrylate; aryl glycidyl ether; vinyl propionate; N, N-dimethylmethacrylamide, N, N-getylmethacrylamide, N- (2-hydroxyethyl) meth
- hydrophilic monomers (E), (meth) acrylamide, hydroxyalkyl (meth) acrylate, and alkylene are preferable because they have excellent compatibility with silicone-containing components and can impart hydrophilicity to ophthalmic lens materials.
- Glycol mono (meth) acrylate, (meth) acrylic acid, N-vinyl lactam and N-vinyl amide are preferred. These can be used alone or in combination of two or more.
- the ophthalmic lens material is manufactured and then treated with an acid or a base to make the ophthalmic lens material more flexible. Properties and surface water wettability.
- Alkyl (meth) acrylate is used to adjust the hardness of ophthalmic lens materials. It is a component that imparts quality and softness.
- alkyl (meth) acrylate examples include methyl (meth) acrylate, ethyl (meth) acrylate, isopropyl (meth) acrylate, n-propyl (meth) acrylate, isobutyl (meth) acrylate, n -Butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, n-octyl (meth) acrylate, n-decyl (meth) acrylate, n -dodecyl (meth) acrylate, t-butyl (meth) Acrylate, pentyl (meth) acrylate, t-pentyl (meth) acrylate, hexyl (meth) acrylate, heptyl (meth) acrylate, nonyl (meth) acrylate, stearyl (meth) acrylate, cyclopentyl (
- Fluorine-containing alkyl (meth) acrylate is a component that improves the anti-lipid contamination of ophthalmic lens materials.
- R 4 is a hydrogen atom or CH 3 , s is an integer of 1 to 15, and t is an integer of 1 to (2s + 1)).
- Specific examples of the compound represented by the general formula (14) include, for example, 2,2,2-trifluoroethyl (meth) acrylate, 2,2,3,3-tetrafluoropropyl (meth) acrylate, 2,2,3,3-tetrafluoro-t-pentyl (meth) acrylate, 2,2,3,4,4,4-hexafluorobutyl (meth) acrylate, 2,2,3,4,4 , Four —Hexafluoro-t-hexyl (meth) acrylate, 2,3,4,5,5,5-hexafluoro-2,4-bis (trifluoromethyl) pentyl (meth) acrylate, 2,2,3 3,4,4-Hexafluorobutyl (meth) acrylate, 2,2,2,2 ', 2', 2'-hexafluoro mouth isopropyl (meth) acrylate, 2,2,3,3,4,4 4-Heptafluorobutyl (meth)
- Alkyl (meth) acrylate and fluorine-containing alkyl (meth) acrylate The content of the salt depends on the essential components such as compound (A) and pyrrolidone derivative (B), as well as the polymerization components such as silicon compound (C), N-substituted acrylamide (D) and hydrophilic monomer (E).
- the content is 20% by weight or less, more preferably 10% by weight or less of the whole polymerizable component so that the effect is sufficiently exhibited.
- the amount of the polymer component is at least 0.01% by weight, preferably at least 0.1% by weight.
- the hardness adjusting monomer is a component that adjusts the hardness of the ophthalmic lens material to impart hardness or softness.
- hardness-controlling monomer examples include alkoxyalkyl (such as 2-ethoxyethyl (meth) acrylate, 3-ethoxypropyl (meth) acrylate, 2-methoxyethyl (meth) acrylate, and 3-methoxypropyl (meth) acrylate.
- alkoxyalkyl such as 2-ethoxyethyl (meth) acrylate, 3-ethoxypropyl (meth) acrylate, 2-methoxyethyl (meth) acrylate, and 3-methoxypropyl (meth) acrylate.
- Alkyl thioalkyl (meth) acrylates such as meth) acrylate; ethyl thioethyl (meth) acrylate, methyl thioethyl (meth) acrylate; styrene; ⁇ -methyl styrene; methyl styrene, ethyl styrene, propyl styrene, butyl styrene, t-butyl styrene, isobutyl Alkyl styrenes such as styrene and pentyl styrene; methyl- ⁇ -methylstyrene, ethyl- ⁇ -methylstyrene, propyl- ⁇ -methylstyrene, butyl_ ⁇ -methylstyrene , T-butyl- ⁇ - methylstyrene, Isobuchiru CK-methylstyrene
- the content of the hardness controlling monomer in the polymerization component is 1% by weight or more, and preferably 3% by weight or more, in order to sufficiently impart the desired hardness or softness to the ophthalmic lens material.
- the amount is preferably 30% by weight or less, and preferably 20% by weight. % Or less.
- Polymerizable and non-polymerizable UV absorbers, dyes, and UV-absorbing dyes are components that impart UV-absorbing properties to ophthalmic lens materials or color the materials.
- polymerizable ultraviolet absorber examples include, for example, 2-hydroxy-4- (meth) acryloyloxybenzophenone, 2-hydroxy-14- (meth) acryloyloxy-5-t _Butylbenzophenone, 2-hydroxy 41- (meth) acryloyloxy 2 ', 4, dicyclo-open benzophenone, 2-hydroxy-41- (2'-hydroxy-3'-(meth) acryloyl Benzophenone-based polymerizable UV absorbers such as benzophenone; 2_ (2'-hydroxy-5 '-(meth) acryloyloxyshetylphenyl) 1-2H-benzotriazole, 2- (2'-hydroxy) 5 ' ⁇ (Meth) acryloyloxyshethylphenyl) 1 5_ ⁇ -2H-benzotriazole, 2- (2'-hydroxy-5'-(meth) acryloyloxypropylphenyl 1) 2H-benzotriazole, 2- (2'-hydroxy-5- (
- the polymerizable dye include, for example, 1_phenylazole (Meth) acryloyloxynaphthalene, 1-phenylazo-2-hydroxy-3- (meth) acryloyloxynaphthylene, 1-naphthylazo-2-hydroxy-3- (meth) acryloyloxy Naphthylene, 1- (a-anthrylazo) 1-2-hydroxy-13- (meth) acryloyloxy naphthalene, 1-1 ((4 '-(phenylenyl) -phenyl) azo) 1-2-hydroxy-1 3 — (Meth) acryloyloxynaphthalene, 1— (2 ', 4, -xylylazo)-2- (meth) acryloyloxynaphthylene, 1- (o-tolylazo) -2- (meth) a Chryloyloxynaphthene, 2- (m- (meth) acrylo
- polymerizable ultraviolet absorbing dye examples include, for example, 2,4-dihydroxy-3 (p-styrenoazo) benzophenone, 2,4-dihydroxy_5- (p-styrenoazo) benzophenone, 2,4-dihydroxy -3-(p- (meth) acryloyloxymethylphenylazo) benzophenone, 2, 4-dihydroxy-5- (p- (meth) acryloyloxymethylphenylazo) benzophenone, 2,4-dihydroxy _ 3— (p- (meth) acryloyloxhetylphenylazo) benzophenone, 2,4-dihydroxy-1-5- (p- (meth) acryloyloxhetylphenylazo ) Benzophenone, 2,4-dihydroxy_3— (p- (meth) acryloyloxyprohylphenylphenylazo) benzophenone, 2,4-dihydroxy- 15- (P— (meth)
- the content of the polymerizable UV absorber, the polymerizable dye and the polymerizable UV-absorbable dye is greatly affected by the thickness of the lens.
- the amount used is 3 parts or less, preferably 0.01 to 2 parts, based on 100 parts of the total amount of the polymerization components. If these amounts exceed 3 parts, the mechanical strength of the ophthalmic lens material tends to decrease. Furthermore, considering the toxicity of ultraviolet absorbers and dyes, they tend to be unsuitable as materials for ophthalmic lenses such as contact lenses that come into direct contact with living tissues and intraocular lenses that are implanted in living bodies.
- the ophthalmic lens to be produced has a low water content and no elution of non-polymerizable UV absorbers, dyes, and UV-absorbing dyes, 2_ (4,6-diphenyl-2-1) , 3,5-triazine-2-yl) 1-5- (hexyloxy) phenol, 2- (5-chloro-2H-benzotriazo-l-2-yl) —6 -— (1,1-dimethylethyl)-
- Non-polymerizable components such as 4-methylphenol can also be used.
- the polymerizable component remains very little, and is basically a crosslinking agent. Do not need. However, a crosslinking agent (G) can be added to control the flexibility and hardness of the material.
- crosslinking agent (G) used in the present invention examples include: aryl methacrylate, vinyl methacrylate, 4-vinylbenzyl methacrylate, 3-vinylbenzyl methacrylate, methacryloyloxyshetyl acrylate, ethylene glycol dimethacrylate, Diethylene glycol dimethacrylate, diethylene glycol diaryl ether, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate Rate, propylene glycol dimethacrylate, dipropylene glycol dimethacrylate, butanediol dimethacrylate, trimethylolpropane trimethacrylate, 2,2-bis (p-methacryloyloxyphenyl) hexafluoropropane, 2,2- Bis (m-methacryloyloxyphenyl) hexafluoropropane, 2,2-bis (o-methacryloyloxyphenyl) hexafluoropropane
- the content of the crosslinking agent (G) should be 1 part or less based on 100 parts by weight (hereinafter referred to as “parts”) of the total amount of the polymerizable components other than the crosslinking agent so as not to make the ophthalmic lens material brittle. And preferably 0.8 part or less. Further, in order to further improve the mechanical strength of the ophthalmic lens material and sufficiently exhibit the effect of imparting durability, it is necessary to add 0.1% to the total amount of 100 parts of the polymerization components other than the crosslinking agent. It is at least 5 parts, preferably at least 0.1 part.
- the cross-linking agent (G) When the cross-linking agent (G) is used in the ophthalmic lens material of the present invention, the compound (A) and the cross-linking agent (G) are used at the same time as a cross-linkable component.
- the polymerizability can be significantly improved, and various physical properties of the obtained ophthalmic lens material can be improved.
- the stress relaxation rate of the ophthalmic lens material of the present invention indicates a stress relaxation rate in 30 seconds under a constant load, and the relaxation rate is preferably 8 to 15%, more preferably 8 to 13%. If it is less than 8%, the material is excellent in resilience but tends to be hard and inflexible without elongation.
- the tensile modulus of the ophthalmic lens material of the present invention is preferably from 0.2 to 0.8 MPa, and more preferably from 0.2 to 0.7 MPa. If it is less than 0.2 MPa, the material has no stiffness and tends to be difficult to handle due to poor shape retention on the fingers for use as an ophthalmic lens.
- both the stress relaxation rate and the tensile modulus are in the preferable ranges. Materials that do not fall within the preferred ranges are more likely to cause adsorption or staining of the cornea and conjunctiva, especially when worn continuously or when napping, making the material unsuitable as a contact lens. I can say. For comfortable wearing, the material must have a good balance between the resilience and flexibility.
- the water content of the ophthalmic lens material of the present invention is preferably 10 to 60% by weight, and more preferably 32 to 55% by weight.
- the water content is less than 10% by weight, the material becomes semi-hard and, for example, when used as a contact lens, the feeling of wearing tends to deteriorate.
- the water content exceeds 60% by weight, the oxygen permeability becomes dependent on the water content, and sufficient oxygen cannot be supplied to the cornea in consideration of the wearing state such as continuous wearing or napping. There is a tendency.
- the ophthalmic lens material of the present invention can be manufactured by the following procedure. a) at least one compound having an ethylenically unsaturated group and a polydimethylsiloxane structure through a urethane bond (A), and a hydrophilic monomer (B) containing at least one pyrrolidone derivative whose polymerizable group is a methylene group. A) obtaining a mixed solution containing a photopolymerization initiator and Z or a thermal polymerization initiator; b) introducing the mixed solution into a mold;
- the mixed solution contains the compound (A), the pyrrolidone derivative (B), the silicone compound (C) and the N-substituted acrylamide (D) in order to express the characteristics of each polymerizable component.
- the mixture contains a water-soluble organic solvent.
- the presence of a very small amount of a non-polymerizable organic solvent with respect to the polymerizable component allows the unreacted monomer to diffuse into the system even after the polymerization reaction has progressed, thereby causing a polymerization reaction. Can be involved. That is, the use of the water-soluble organic solvent can reduce the remaining polymerizable components.
- the water-soluble organic solvent used in the present invention includes alcohols having 1 to 4 carbon atoms such as methanol, ethanol, 1-propanol and 2-propanol, or acetone, methyl ethyl ketone, dimethylformamide, dimethyl sulfoxide, acetonitrile and Select from N-methyl-2-pyrrolidone Is a water-soluble organic solvent.
- the organic solvent one that can dissolve the used polymerizable component may be appropriately selected and used according to the type of the polymerizable component. These may be used alone or as a mixture of two or more.
- the water-soluble organic solvent in the present invention can dissolve the polymerizable component for an ophthalmic lens material.
- the amount used in the mixed solution is preferably 5% by weight or less, more preferably 0.1 to 5% by weight, and even more preferably 0.2 to 4% by weight. If the amount used is less than 0.1% by weight, the amount of residual components during polymerization tends to increase. On the other hand, if it exceeds 5% by weight, the mixture of the polymerizable components to which the diluent has been added becomes non-uniform, phase separation occurs during the polymerization reaction performed later, and the resulting material tends to become cloudy.
- the organic solvent used is water-soluble, it can be easily replaced with water in the subsequent elution treatment step.
- the compound (A) and the pyrrolidone derivative (B) as essential components, and if necessary, the silicone compound (C) and the N-substituted acrylamide (D)
- the amount of the hydrophilic monomer (E), the amount of the monomer (F) and the amount of the cross-linking agent (G) are appropriately adjusted so as to be within the above ranges, and the polymerization component is heated and subjected to Z or ultraviolet irradiation. Polymerize by the te type method.
- the desired ophthalmic lens After blending the polymerization component and the radical polymerization initiator in the mold corresponding to the shape of the above, the mold is gradually heated to polymerize the polymerization component. Apply mechanical processing such as polishing.
- the cutting may be performed over at least one surface or both surfaces of the molded body (copolymer), or may be performed on at least one surface or both surfaces of the molded body (copolymer). It may be performed for a part.
- the ophthalmic lens material of the present invention is obtained by cutting at least one surface or a part of a molded product (copolymer) in consideration of giving a wide range of uses of products such as special lenses. Is particularly preferred.
- Cutting at least one surface of such a molded article means performing blanks molding, that is, cutting blanks obtained by polymerization by a ⁇ mold method to obtain a desired ophthalmic lens shape. It is a concept that includes The polymerization may be performed by, for example, a bulk polymerization method or a solution polymerization method using a solvent or the like.
- radical polymerization initiator examples include, for example, 2,2′-azobisisobutyronitrile, 2,2′-azobis (2,4-dimethylvaleronitrile), benzoyl peroxide, and t-butylhydroperoxide.
- Oxide cumene hydroperoxide, lauroyl peroxide, t-butyl peroxyhexanoate, 3,5,5-trimethylhexanoyl peroxide. These can be used alone or in combination of two or more.
- the amount of the radical polymerization initiator is about 0.001 to 2 parts, preferably 0.01 to 1 part, per 100 parts of the polymerization component.
- the heating temperature for heating the polymerization component in the mold is 50 ° C.
- the temperature is 150 ° C. or lower, preferably 140 ° C. or lower, in terms of suppressing volatilization of each polymerization component and preventing deformation of the mold.
- the heating time when heating the polymerization component in the mold is as follows. The time is at least 10 minutes, and preferably at least 20 minutes, from the viewpoint of shortening the reaction time and reducing the residual monomer component. Further, from the viewpoint of preventing deformation of the mold, the heating time is 120 minutes or less, preferably 60 minutes or less. The heating may be performed by gradually increasing the temperature.
- the polymerization component When the polymerization component is polymerized by UV irradiation by UV irradiation, the polymerization component and the photopolymerization initiator are blended into a mold corresponding to the desired ophthalmic lens shape, and then UV irradiation is performed on the mold. Irradiation polymerizes the polymerization components, and the obtained molded body is subjected to mechanical processing such as cutting and polishing as necessary.
- the cutting may be performed on at least one surface or both surfaces of the molded body (copolymer), or may be performed on at least one surface or part of both surfaces of the molded body (copolymer). May be performed.
- At least one surface of a molded article (copolymer) or a part of the molded article (copolymer) was cut in consideration of giving a wider range of uses of products such as special lenses. It is particularly preferred that it is. Cutting at least one surface of such a molded article (copolymer) means that blanks molding is performed in the same manner as in the case of a molded article (copolymer) obtained by heating the above-mentioned polymerization component. In other words, the concept includes cutting a blank obtained by polymerization by a mold method into a desired ophthalmic lens shape.
- the polymerization may be performed by a bulk polymerization method or a solution polymerization method using a solvent or the like.
- polymerization is carried out by irradiation with ultraviolet rays as described above, but electron beam irradiation can be carried out instead of such ultraviolet irradiation.
- the heavy component is polymerized without a photopolymerization initiator.
- the ⁇ -shaped material used for polymerization by ultraviolet irradiation is preferably a general-purpose resin such as polypropylene, polystyrene, nylon, or polyester, which can transmit ultraviolet rays necessary for curing the material, and may be glass. These are formed and processed into a desired shape.
- a polymerizable component and a photopolymerization initiator, a dye, a UV absorber, and an organic diluent in a type II that has or has not been adapted the type II is irradiated with ultraviolet light to polymerize the polymerizable component. carry out.
- the wavelength range of the irradiated UV can be selected according to the function of the ophthalmic lens material. However, it is necessary to select the type of photopolymerization initiator to be used depending on the UV wavelength range to be irradiated.
- the preferred UV illuminance when irradiating the polymerization component in the mold with UV is 1.O mWZ cm 2 or more in order to sufficiently cure the material, and 5 O mWZ cm 2 for the purpose of preventing material deterioration. It is as follows.
- the irradiation time is preferably 1 minute or more in order to sufficiently cure the material. Irradiation with ultraviolet light may be performed in one step, or ultraviolet light of different illuminance may be irradiated stepwise. Furthermore, during the polymerization, heating may be performed simultaneously with the irradiation of ultraviolet rays, whereby the polymerization reaction is promoted, and an ophthalmic lens can be effectively molded.
- the heating temperature is preferably 25 ° C. or higher, more preferably 30 ° C. or higher, from the viewpoint of accelerating the reaction. Or less, more preferably 90 ° C. or less.
- the obtained molded body is subjected to machining such as cutting and polishing as necessary.
- the cutting may be performed on at least one or both surfaces of the molded body (copolymer), or may be performed on at least one or both surfaces of the molded body (copolymer). You may go to.
- the ophthalmic lens material of the present invention is obtained by cutting at least one surface of a molded article (copolymer) or a part of the molded article (copolymer) in consideration of giving a wider range of uses of products such as special lenses.
- Cutting at least one surface or a part of the molded body (copolymer) means that planks obtained by polymerization by a ⁇ method are cut into a desired ophthalmic lens shape. It is a concept that includes.
- the polymerization is performed by irradiating ultraviolet rays as described above, but electron beam irradiation may be performed instead of such ultraviolet irradiation.
- the polymerizable component can be polymerized without a photopolymerization initiator.
- photopolymerization initiator examples include, for example, 2,4,6-trimethylbenzoyl-diphenylphosphine oxide (TPO) and bis (2,4,6-trimethylbenzoyl) -phenylphosphine oxide.
- TPO 2,4,6-trimethylbenzoyl-diphenylphosphine oxide
- bis (2,4,6-trimethylbenzoyl) -phenylphosphine oxide examples include, for example, 2,4,6-trimethylbenzoyl-diphenylphosphine oxide (TPO) and bis (2,4,6-trimethylbenzoyl) -phenylphosphine oxide.
- Phosphinoxide photopolymerization initiator methyl orthobenzoyl benzoate, methyl benzoyl formate, benzoin methyl ether, benzoine ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, benzoin-n- Benzine photopolymerization initiators such as butyl ether; 2-hydroxy-2-methyl-1-phenylpropane-1-one, p-isopropyl-1- ⁇ hydroxyisobutylphenone, p-t-butyltrichloroacetophenone, 2, 2-dimethoxy-1-phenyl acetophenone Phenone-based photopolymerization initiators such as, ⁇ -dichloro-4-phenoxyacetophenone, ⁇ , ⁇ -tetraethyl-4,4-diaminobenzophenone; 1-hydroxycyclohexylphenyl ketone; 1-phenyl-1,2 _ Propandione
- a photosensitizer may be used together with the photopolymerization initiator.
- the content of the photopolymerization initiator and the photosensitizer is about 0.001 to 2 parts, preferably 0.01 to 1 part, based on 100 parts of the polymerization component.
- the lens support portion In both cases where the polymerization component is heated and polymerized and when the polymerization is performed by irradiating ultraviolet rays or electron beams, when the intraocular lens is manufactured, the lens support portion must be manufactured separately from the lens. May be attached to the lens, or may be molded integrally with the lens. In order to improve the surface characteristics of the ophthalmic lens, the following surface treatment can be performed. By these surface treatments, an ophthalmic lens material surface having more excellent water wettability and / or stain resistance can be produced.
- a dilute gas atmosphere such as alkenes having 1 to 6 carbon atoms and fluorine-substituted alkanes, nitrogen, oxygen, argon, hydrogen, air, water, silane or a mixture thereof, which are known to those skilled in the art.
- Low-temperature plasma treatment can be performed under specific conditions.
- oxygen alone or oxygen, water, and tetrafluur are expected because of the physical surface modification effect of ion etching and chemical surface modification by radical implantation (introduction of oxygen atoms). Mixtures with dichloromethane, organosilanes, methane, and nitrogen are preferred.
- the low-temperature plasma treatment may be performed under reduced pressure (low pressure) or under atmospheric pressure.
- Low-temperature low-pressure plasma processing or low-temperature atmospheric-pressure plasma processing includes high-frequency RF (for example, 13.56 MHz) and low-frequency AF (for example, 15.0 to 40.0 KHz), microwave (for example, 2.45 MHz). GHz), output (optimal value varies depending on frequency), processing time (from microsecond processing to about 1 hour), gas concentration (low pressure, low pressure, eg 10 to 150 Pa) Thereby, the surface modification effect can be controlled.
- the surface produced by these methods is excellent in water wettability and Z or contamination resistance, and is also excellent in durability of its properties, and can be suitably used as an ophthalmic lens material.
- a method known to those skilled in the art can be used as a method for forming a hydrophilic polymer film.
- a surface modification method using a plasma polymerized film by performing glow discharge (plasma) in an atmosphere of a gasified hydrophilic monomer can be used.
- plasma glow discharge
- monomer fragments and active species are recombined randomly with the substrate, and in addition, polymerization of the monomer from the generated radicals occurs, forming an irregular and highly crosslinked polymer film on the substrate surface. Can be done.
- the plasma polymerization is performed, for example, under the following conditions.
- Plasma gas flow rate (argon, nitrogen, etc .: 1 to 50 s c cm)
- Glow discharge (frequency 13.56 ⁇ ⁇ , output 30 ⁇ 100, pressure 1.0 ⁇ 30Pa).
- the hydrophilic monomer used here is not limited as long as it is a compound that can be gasified under low pressure and heating.
- pyridone derivatives such as 1-alkyl-3-methylene-1-pyrrolidone, vinyl lactams such as N-VP,
- Acrylamide such as DMA A, (meth) acrylic acid, hydroxyalkyl (Meth) acrylate.
- radicals are generated on the substrate surface by performing plasma treatment in a gas atmosphere such as oxygen, nitrogen, or argon, and then the ophthalmic lens material is immersed in a hydrophilic monomer solution and cured by UV irradiation or heating.
- a gas atmosphere such as oxygen, nitrogen, or argon
- the ophthalmic lens material is immersed in a hydrophilic monomer solution and cured by UV irradiation or heating.
- the conditions of UV irradiation and heating for forming the polymer film are not particularly limited. It is possible to select the conditions under which the used monomer can be sufficiently cured. For example, as UV irradiation conditions, it is effective to repeatedly perform irradiation for 1 to 30 minutes at an illuminance of 0.5 to 15 mW / cm 2 (365 nm) as necessary.
- UV irradiation or heat treatment may be performed in a state of being immersed in the hydrophilic monomer solution or in a state of stirring, or after immersion, in a state where the base material is taken out or dried. Is also good.
- hydrophilic monomer used herein examples include pyrrolidone derivatives such as 1-alkyl-13-methylene-12-pyrrolidone, vinyl lactams such as N-VP, acrylamides such as DMAA, (meth) acrylic acid, and hydroxyalkyl ( Contains zwitterions such as (meth) acrylate, 2-methacryloyloxyshethylphosphorylcholine (MPC) and N- (3-sulfopropyl) methacryloyloxyethylene N, N-dimethylammonium betaine (SPE) Compounds and mixtures thereof.
- the monomer is graft-polymerized starting from the radical on the surface of the base material.
- Crosslinking agents include ethylene glycol dimethacrylate (EDMA), polyethylene glycol di (meth) acrylate, aryl methacrylate (AMA), and diethylene glycol diaryl. Ether and the like.
- EDMA ethylene glycol dimethacrylate
- AMA polyethylene glycol di (meth) acrylate
- AMA aryl methacrylate
- diethylene glycol diaryl. Ether and the like there is no particular limitation on the crosslinking agent that can be used.
- the crosslinking agent can be appropriately selected depending on the monomer and the solvent used.
- the solvent used is not particularly limited, and examples thereof include water, water-soluble solvents such as methanol, ethanol, 2-propanol, acetone, acetonitrile, and THF.
- the obtained molded product is essentially a water-containing material
- a molded product made into an ophthalmic lens shape by cutting or an ophthalmic lens-shaped molded product removed from a mold (2) is used.
- the desired ophthalmic lens material shape can be obtained, and at the same time, unpolymerized polymerizable components and organic diluents can be removed.
- distilled water or physiological saline may be heated simultaneously with or after hydration of the lens.
- the heating temperature is preferably lower than the temperature at which the residue can be removed in a short time and lower than the deformation temperature of the ophthalmic lens material, for example, preferably 35 to 100 ° C.
- the colorless and transparent lens after the elution treatment can be colored using a vat dye.
- Vat dyes used include indanthrone, pyranthrone, benzantrone, anthraquinone carbazole, anthraquinoxazole, and indigo dyes.
- Preferred examples are CI VAT BLUE 4, CI VAT BLUE 6, CI VAT BROWN 1 for indantron systems, C.I.VAT GREEN 1 for pyranthrone systems, and C.I.VAT BROWN 2, for anthraquinone carbazole systems.
- CI VAT B LUE 1 and the like can be mentioned.
- the steps of dyeing these vat dyes include the following steps.
- vat dyes are important because they greatly affect their dyeability. Generally affected by alkali concentration, reducing agent concentration, and reducing / staining temperature. In addition, the solubility of the leuco compound and the affinity for the base material also have a great influence on the dyeing properties.
- the reduction conditions were as follows: caustic soda concentration: 0.0050-5.0 mol / L, sodium hydrosulfite sodium reducing agent concentration: 0.001-50 g / L, reduction temperature: room temperature-80 ° C, dyeing The temperature is also preferably between room temperature and 80 ° C.
- the dye concentration is preferably from 0.0001 to 1.0 gZL.
- a water-insoluble vat dye that has been converted into a leuco sulfate ester by a soluble vat dye in advance is also possible.
- a water-insoluble vat dye that has been converted into a leuco sulfate ester by a soluble vat dye in advance is also possible.
- C.I.so1ubii1isedVATBLUE6 in the indantron system C.I.solobulilisedVAT GREE N1 in the pyrantronic system
- C.I.solublilisedVATBLUE1 in the indigo system.
- the soluble vat dye can be directly mixed with the raw monomer solution of the ophthalmic lens material and used.
- the ophthalmic lens material of the present invention obtained in this way has properties such as high oxygen permeability and high mechanical strength, excellent surface water wettability, and excellent surface lubricity and Z wettability. Since it has both functions, it can be preferably used for, for example, contact lenses, intraocular lenses, artificial cornea, corneal onlay, and corneal inlay.
- the ophthalmic lens material of the present invention will be described in more detail based on examples, but the present invention is not limited to these examples.
- IPD I isophorone diisocyanate
- FeAA iron acetyl acetate
- IPD I isophorone diisocyanate
- FeAcAc iron acetyl acetonate
- TRIS Tris (trimethylsiloxy) silylpropyl methacrylate
- DMAA N, N-dimethylacrylamide
- N—VP N—vinyl-1-pyrrolidone
- EDM A Ethylene Dalicol Dime Cryate
- TPO 2,4,6-trimethylbenzoyl-diphenylphosphinoxide
- HMP PO 2-hydroxy-2-methyl lip mouth piofenone
- BAPO Bis (2,4,6-trimethylbenzoyl) monophenylphosphoxide
- ADMVN 2,2'azobis (2,4-dimethylvaleroni
- CBDMP 2- (5-chloro-2H-benzotriazole-2-yl) -1-6- (1,1-dimethylethyl) -14-methylphenol
- BZT-MA 2- (2, -Hydroxy_5 '-(2' '-methacryloyloxyethoxy) -1,3,1-t-butylphenyl) -1,5-methyl-1 2H-benzotriazole
- APMA tetra- (4-methacrylamide) copper phthalocyanine
- PAMNp 1 _phenylazole 3-methacryloyloxy 2-naphthol
- the amounts (parts by weight) of the crosslinking agent, the polymerization initiator, the ultraviolet absorber, the coloring agent and the diluent in the table are based on 100 parts by weight of the other polymerizable components. Quantification of residual monomer in the contact lens polymer obtained in Example, quantification of eluate in the treatment solution after hydration treatment, contact lens transparency, surface lubricity, water wettability, contact angle The resilience, tensile elasticity, oxygen permeability, refractive index, water content and lipid adhesion were examined according to the following methods.
- the lens taken out of the mold was immersed in acetonitrile to extract residual components.
- This extract was analyzed by HPLC, and the residual ratio of 1,3-MMP, 1,5-MMP, 5,3-MMP or N-VP with a relatively large amount of monomer relative to the blended amount was determined.
- the residual ratio prepare a solution of 1,3-MMP, 1,5-MMP, 5,3-MMP or N-VP of known concentration in acetonitrile and analyze by HPLC, and A calibration curve was prepared by taking each monomer concentration (ppm) on the X-axis and each peak area analysis value on the y-axis.
- Residual rate S per amount of pyrrolidone monomer used 1 (%), residual ratio to the total amount of lens S 2 (%) is V: amount of extraction solvent (mL), A: peak area of monomer, a: slope of calibration curve, b: section of calibration curve, W: plate Weight (g), w: expressed as follows, using the weight fraction (%) of the target monomer at the time of blending.
- Example 1 and Comparative Example 1 immediately after the polymerization were used as samples. After weighing these samples, they were individually placed in vials containing 2 OmL of ultrapure water, and autoclaved at 121 ° C for 10 minutes. Five samples of the same material were prepared. Immediately after cooling (day 0), the lenses were taken out on days 1, 3, 8, and 14 after processing, and the processing solution was analyzed by TOC. The measurement was performed in NP OC (Non Purgeable Organic Carbon) mode using a total organic carbon meter (T ⁇ C) TOC-V cs complaint) manufactured by Shimadzu Corporation, and the results are shown in Table 4. The quantitative value (ppmC) shows the concentration of the extract when the concentration immediately after autoclaving (day 0) is set to 0. In other words, a large value indicates a large amount of elution.
- NP OC Non Purgeable Organic Carbon
- the appearance of the contact lens was visually observed and evaluated based on the following evaluation criteria.
- A No fogging, excellent transparency, and suitable for contact lenses.
- A Good water wettability, good sliding between lenses, and suitable as a contact lens.
- D The surface of the lens is sticky, and the adhesion between the lens and fingers is strong.
- the contact angle (°) (bubble method) was measured in saline solution at a temperature of 25 ° C using a contact angle meter G-I, 2MG manufactured by Elma Sales Co., Ltd. Using a syringe, 10 L of air bubbles were attached to the film immersed in the physiological saline solution, and the contact angle values of the air bubbles and the right and left angles of the plate were averaged to obtain a contact angle value. The smaller the contact angle value, the better the water wettability.
- the periphery of the ophthalmic lens material was fixed, and the center was fixed to a device for applying a load with a spherical jig having a tip diameter of 1/16 inch.
- the ophthalmic lens material was stopped by applying a load of about 20 g, and the stress immediately after the stop (S o (g / mm 2 )) was measured. After leaving it for 30 seconds, the stress (S (g / mm 2 ) was measured. Using the measured SO and S, the stress relaxation rate (%) was calculated according to the following equation.
- the ophthalmic lens material When the value of the stress relaxation rate is 15% or more, the ophthalmic lens material has poor resilience, poor shape recovery, and cannot be said to have appropriate flexibility as an ophthalmic lens material.
- a dumbbell-shaped sample with a width of 2 mm and a thickness of 0.3 mm was punched out using a universal instrument testing machine, Mode 14300, and a tensile test was performed. The measurement was performed in a physiological saline solution at 35 ° C, and Young's modulus (MPa) was calculated from the stress-elongation curve. If the Young's modulus is greater than 0.8 MPa, the ophthalmic lens material has high elasticity, and when the lens is worn, there is a high possibility that the ocular lens will have an obstacle such as sticking of the lens or corneal tinning.
- the oxygen permeability coefficient of the test piece was measured in physiological saline at 35 ° C using a Kakenhi type film oxygen permeability meter manufactured by Rika Seiki Kogyo Co., Ltd. In each case, a cigarette paper was used, and a test piece having a thickness of 0.1 to 0.4 mm was measured in accordance with ISO 9913-1. Calculation was performed taking into account the edge effect, and Menicon EX (manufactured by Menicon) was used as a reference lens standard. The Dk value was normalized to 64.
- the refractive index (no unit) was measured using an Atago refractometer 1T manufactured by Atago Co., Ltd. in an atmosphere at a temperature of 25 ° C and a humidity of 50%. (Moisture content)
- the water content (% by weight) of the test piece was measured according to the following equation.
- W is the weight (g) of the test piece in the equilibrium hydrated state after the hydration treatment, and W is the same.
- the lens was immersed in an artificial eye oil solution consisting of oleic acid, tripalmitin, palmitic acid, cholesterol, cholesterol palmitate and egg yolk lecithin at 37 ° C for 5 hours, and extracted with ethanol and getyl ether.
- the adhesion amount (mg / cm 2 ) was quantified by vanillin phosphate sulfate method.
- An ophthalmic lens component obtained by mixing a polymerizable component and a polymerization initiator shown in Table 1 was injected into a contact lens-shaped ⁇ (made of polypropylene, corresponding to a contact lens having a diameter of about 13 mm and a thickness of 0.1 mm). .
- this mold was irradiated with UV light for 60 minutes to carry out photopolymerization to obtain a contact lens-shaped polymer.
- Tables 2 and 3 show the results of evaluating the amount of unreacted residual monomers in the polymer
- Table 4 shows the results of evaluating the eluate concentration by TOC in the treated solution after hydration.
- An ophthalmic lens component obtained by mixing a polymerizable component, a polymerization initiator, a UV absorber, a colorant and a diluent shown in Tables 5 to 9 was injected into a mold (polypropylene) having a contact lens shape. Next, this mold was irradiated with UV light for 30 minutes to carry out photopolymerization to obtain a contact lens-shaped polymer. The obtained polymer was subjected to plasma irradiation (RF output 50 W, pressure 100 Pa) for 3 minutes in an oxygen atmosphere. It was immersed in physiological saline, absorbed, and hydrated to obtain a contact lens. The evaluation results are shown in Tables 10 to 14. Table 5 Mixing ratio of monomers (parts by weight)
- J undetermined Poor lens shape retention (deformation) and damage due to insufficient mechanical strength.
- the obtained polymer before hydration was subjected to plasma irradiation (output 50 W, pressure 100 Pa, 3 minutes) under an oxygen atmosphere. After that, the graft-polymerized membrane was immersed in a 5.0 mol% aqueous solution of N-VP (containing 5.0% by weight of diethyleneglycol-diaryldiether) and heated at 60 ° C for 30 minutes. Was formed. Hydration treatment was performed to obtain a contact lens. Table 15 shows the evaluation results. Examples 34 and 35
- the obtained polymer before hydration was subjected to plasma irradiation (output 50 W, pressure 100 Pa, 3 minutes) in an oxygen atmosphere, and then Immerse in a 1.0 mol% aqueous solution of MPC (2-methylacryloyloxetylphosphorylcholine) (containing 5.0% by weight of tetraethyleneglycol dimethacrylate) and perform UV irradiation for 10 minutes.
- MPC 2-methylacryloyloxetylphosphorylcholine
- the obtained polymer before hydration was subjected to a glow discharge (TES) in an atmosphere of tetramethoxysilane (TMS) Z oxygen (gas flow ratio of 12 sccm). Pressure 13Pa, RF output 40W, 5 minutes X2 times) to form a plasma polymerized film. Hydration treatment was performed to obtain a contact lens. Table 15 shows the evaluation results.
- Example 16 Using the same mixed solution as in Example 1, the obtained polymer before hydration was subjected to plasma irradiation (output 50 W, pressure 100 Pa, 3 minutes) in an oxygen atmosphere, and then hydration was performed. After the treatment, a contact lens was obtained. Table 16 shows the evaluation results.
- the polymer before hydration obtained by using the same mixed solution as in Example 11 was irradiated with plasma in an atmosphere of oxygen Z water (gas flow ratio 9/1) (output: 2.5 KW, pressure: 133 Pa, After 3 minutes), a hydration treatment was performed to obtain a contact lens.
- Table 16 shows the evaluation results.
- Example 16 Using the same mixed solution as in Example 1, the obtained polymer before hydration was dissolved in water. A sum treatment was performed to obtain a contact lens. Table 16 shows the evaluation results.Table 16 Physical and chemical property evaluation results
- the contact lenses obtained in the same procedure as in Examples 1, 11 and 21 were used to obtain colored contact lenses using a vat dye by the following method.
- the contact lens after the 7K treatment is immersed in a reducing solution consisting of 0.1 g of sodium hydroxide, 0.1 lg of sodium hydroxide, and 19.8 g of purified water.
- a reducing solution consisting of 0.1 g of sodium hydroxide, 0.1 lg of sodium hydroxide, and 19.8 g of purified water.
- About 2.0 g of the staining solution in which 300 ppm of each of the various vat dyes shown in Fig. 10 were dissolved was mixed with the reducing solution in which contact lenses had been immersed in advance, stirred for 15 minutes, and thoroughly washed. Contact lenses were obtained.
- Table 17 shows the evaluation results. Table 17 Coloring with Vat dye
- An ophthalmic lens component obtained by mixing a polymerizable component, a polymerization initiator, a UV absorber, a coloring agent, and a diluent shown in Table 18 was injected into a type I (polypropylene) having a contact lens shape. Then, the mold was heated in an oven adjusted to 100 ⁇ 2 ° C for 30 minutes to obtain a contact lens-shaped polymer. The obtained polymer was subjected to plasma irradiation (RF output 50 W, pressure 100 Pa) for 3 minutes in an oxygen atmosphere. The contact lens was immersed in a physiological saline solution and subjected to hydration by absorbing water to obtain a contact lens. Table 19 shows the evaluation results.
- the contact lenses described in Examples 4, 8, 17, 17, 32, and 34 gave a good wearing feeling when worn, and no obstruction of the anterior segment was observed.
- the wearing feeling was inferior to the contact lens described in the example.
- the wearing test of the contact lens described in Comparative Example 3 having low rebound The amount of movement was small and slow, and adsorption on the cornea was observed.
- the contact lens materials shown in Examples 1 to 55 are excellent in transparency and low friction, have high surface water wettability, and are flexible because the stress relaxation rate is 13% or less. Excellent in repellency and repellency, low in residual ratio of monomer, and low in elution into autoclave solution, so high safety. In addition, it can be seen that it is suitable as a contact lens, such as giving a good wearing feeling even when wearing a contact lens.
- the ophthalmic lens manufacturing process can be shortened because the residual ratio of the pyrrolidone derivative in the lens after polymerization is low.
- the materials of the comparative examples having composition ranges not included in the claims are excellent in transparency, low friction, flexibility, and surface water wettability, but have a high residual ratio of monomers, and are not suitable for use in autoclaving solutions. Elution is also observed, and adsorption is also observed when the lens is worn. Industrial applicability
- the present invention has excellent transparency, oxygen permeability, flexibility, resilience, surface wettability and lubricity, low surface tackiness, and appropriate mechanical strength.
- a contact lens having a low residual ratio, a small amount of monomer eluted into the autoclave solution, a high safety and a good feeling of wearing can be obtained.
- an ophthalmic lens material composed of a pyrrolidone derivative in which the polymerizable group is a methylene group and a specific silicone-containing mac-mouth monomer is excellent in polymerizability, and is excellent in polymerizability. It can be used as a highly safe ophthalmic lens material for corneal onlays and corneal inlays.
- the present invention is not limited to contact lenses, and is a versatile ophthalmic lens. Provide the material of the lens.
- the residual pyrrolidone derivative in which the polymerizable group in the lens is a methylene group after polymerization is obtained. Since the rate is low, the manufacturing process can be simplified.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT04700780T ATE507501T1 (de) | 2003-01-10 | 2004-01-08 | Hochsicheres silikonhaltiges material für eine okularlinse und herstellungsprozess dafür |
DE602004032420T DE602004032420D1 (de) | 2003-01-10 | 2004-01-08 | Hochsicheres silikonhaltiges material für eine okularlinse und herstellungsprozess dafür |
JP2005507976A JP4235204B2 (ja) | 2003-01-10 | 2004-01-08 | 安全性の高いシリコーン含有眼用レンズ材料およびその製造方法 |
EP04700780A EP1582910B1 (en) | 2003-01-10 | 2004-01-08 | Highly safe silicone-containing material for ocular lens and process for producing the same |
US10/541,746 US8124668B2 (en) | 2003-01-10 | 2004-01-08 | Silicone-containing ocular lens material with high safety and preparing method thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-004951 | 2003-01-10 | ||
JP2003004951 | 2003-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004063795A1 true WO2004063795A1 (ja) | 2004-07-29 |
Family
ID=32708989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/000071 WO2004063795A1 (ja) | 2003-01-10 | 2004-01-08 | 安全性の高いシリコーン含有眼用レンズ材料およびその製造方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8124668B2 (ja) |
EP (2) | EP2180366B1 (ja) |
JP (1) | JP4235204B2 (ja) |
CN (1) | CN100529842C (ja) |
AT (1) | ATE507501T1 (ja) |
DE (1) | DE602004032420D1 (ja) |
WO (1) | WO2004063795A1 (ja) |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008511870A (ja) * | 2004-08-27 | 2008-04-17 | 旭化成アイミー株式会社 | シリコーンヒドロゲルコンタクトレンズ |
JP2009014977A (ja) * | 2007-07-04 | 2009-01-22 | Seed Co Ltd | 含水性眼用レンズ |
WO2009044853A1 (ja) * | 2007-10-04 | 2009-04-09 | Menicon Co., Ltd. | 眼用レンズ用着色剤、眼用レンズ用材料、眼用レンズの製造方法および眼用レンズ |
US7540609B2 (en) * | 2006-06-15 | 2009-06-02 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
WO2009099164A1 (ja) | 2008-02-08 | 2009-08-13 | Asahi Kasei Aime Co., Ltd. | 親水性ポリシロキサンマクロモノマー、その製造および用途 |
JP2011219512A (ja) * | 2010-04-02 | 2011-11-04 | Menicon Co Ltd | 重合性組成物、ポリマー材料、眼用レンズ及びコンタクトレンズ |
WO2012057096A1 (ja) | 2010-10-25 | 2012-05-03 | 株式会社メニコン | アゾ色素、眼用レンズ材料、眼用レンズ材料の製造方法及び眼用レンズ |
JP2012513042A (ja) * | 2008-12-18 | 2012-06-07 | ノバルティス アーゲー | シリコーンハイドロゲルコンタクトレンズの製造方法 |
US8231218B2 (en) | 2006-06-15 | 2012-07-31 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
KR101210417B1 (ko) | 2005-09-05 | 2012-12-10 | 호야 가부시키가이샤 | 콘택트렌즈 재료의 제조 방법 및 소프트 콘택트렌즈의 제조방법 |
JP2013504682A (ja) * | 2009-09-15 | 2013-02-07 | ノバルティス アーゲー | 紫外線吸収性コンタクトレンズの製造に適したプレポリマー |
WO2013024880A1 (ja) * | 2011-08-17 | 2013-02-21 | 東レ株式会社 | 低含水性軟質眼用レンズおよびその製造方法 |
JP2013163819A (ja) * | 2007-11-13 | 2013-08-22 | Toagosei Co Ltd | ウレタン(メタ)アクリレートの製造方法 |
JP2013540188A (ja) * | 2010-10-06 | 2013-10-31 | ノバルティス アーゲー | ダングリング親水性ポリマー鎖を有する連鎖延長ポリシロキサン架橋剤 |
CN103406973A (zh) * | 2013-07-25 | 2013-11-27 | 中南大学 | 一种醇水基料浆凝胶注模制备多孔或致密材料的成型工艺 |
JP2014089477A (ja) * | 2006-06-15 | 2014-05-15 | Coopervision Internatl Holding Co Lp | 湿潤性シリコーンヒドロゲルコンタクトレンズ及び関連組成物及び方法 |
JP2015508425A (ja) * | 2011-12-14 | 2015-03-19 | センプラス・バイオサイエンシーズ・コーポレイションSemprus Biosciences Corp. | 表面改質したコンタクトレンズ |
WO2015092859A1 (ja) * | 2013-12-16 | 2015-06-25 | 株式会社メニコン | 眼用レンズ |
WO2015092858A1 (ja) * | 2013-12-16 | 2015-06-25 | 株式会社メニコン | 眼用レンズ用ポリシロキサン系マクロモノマー及びそれを用いた眼用レンズ |
WO2015186620A1 (ja) * | 2014-06-03 | 2015-12-10 | 株式会社 メニコン | コンタクトレンズおよびその製造方法 |
WO2015186634A1 (ja) * | 2014-06-03 | 2015-12-10 | 株式会社 メニコン | コンタクトレンズおよびその製造方法 |
JP2016511841A (ja) * | 2013-02-12 | 2016-04-21 | 康夫 松澤 | シリコーンコンタクトレンズ及びその製造方法 |
JP2016133593A (ja) * | 2015-01-19 | 2016-07-25 | 株式会社メニコン | コンタクトレンズの製造方法 |
JP2018045232A (ja) * | 2016-09-02 | 2018-03-22 | 星歐光學股▲ふん▼有限公司 | コンタクトレンズ製品 |
JP2018106189A (ja) * | 2010-07-30 | 2018-07-05 | ノバルティス アーゲー | 架橋親水性コーティングを備えるシリコーンヒドロゲルレンズ |
US10845622B2 (en) | 2015-09-15 | 2020-11-24 | Largan Medical Co., Ltd. | Multifocal contact lens and contact lens product |
US10961341B2 (en) | 2018-01-30 | 2021-03-30 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use |
RU2748735C2 (ru) * | 2016-08-05 | 2021-05-31 | Джонсон Энд Джонсон Вижн Кэа, Инк. | Полимерные композиции, содержащие привитые полимерные сетки, и способы их получения и применения |
US11034789B2 (en) | 2018-01-30 | 2021-06-15 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices containing localized grafted networks and processes for their preparation and use |
WO2022224717A1 (ja) * | 2021-04-19 | 2022-10-27 | 国立研究開発法人物質・材料研究機構 | 軟質眼用レンズ及びその製造方法 |
US11912800B2 (en) | 2021-09-29 | 2024-02-27 | Johnson & Johnson Vision Care, Inc. | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9322958B2 (en) | 2004-08-27 | 2016-04-26 | Coopervision International Holding Company, Lp | Silicone hydrogel contact lenses |
DE102008000721A1 (de) | 2008-03-18 | 2009-09-24 | Evonik Degussa Gmbh | Strahlenhärtbare Formulierungen |
US8163358B2 (en) * | 2009-02-18 | 2012-04-24 | Synergeyes, Inc. | Surface modification of contact lenses |
JP5563277B2 (ja) * | 2009-10-30 | 2014-07-30 | 株式会社シード | 含水性眼用レンズ |
KR101908638B1 (ko) * | 2010-11-17 | 2018-12-19 | 비와이케이-케미 게엠베하 | 폴리실록산-함유 우레탄계 마크로모노머로부터 제조될 수 있는 공중합체, 그의 제조방법 및 그의 용도 |
US9188702B2 (en) | 2011-09-30 | 2015-11-17 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels having improved curing speed and other properties |
HUE029018T2 (en) | 2011-10-12 | 2017-02-28 | Novartis Ag | A method for producing UV absorbing contact lenses by coating |
US8937110B2 (en) | 2011-12-23 | 2015-01-20 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels having a structure formed via controlled reaction kinetics |
MY172901A (en) | 2012-12-17 | 2019-12-13 | Alcon Inc | Method for making improved uv-absorbing ophthalmic lenses |
US9296764B2 (en) * | 2013-12-10 | 2016-03-29 | Momentive Performance Materials Inc. | Hydrophilic silicone composition |
MY180543A (en) | 2013-12-17 | 2020-12-01 | Novartis Ag | A silicone hydrogel lens with a crosslinked hydrophilic coating |
SG10201901379TA (en) | 2014-08-26 | 2019-03-28 | Novartis Ag | Method for applying stable coating on silicone hydrogel contact lenses |
EP3391101B1 (en) | 2015-12-15 | 2020-07-08 | Alcon Inc. | Method for applying stable coating on silicone hydrogel contact lenses |
RU2766412C2 (ru) | 2017-06-07 | 2022-03-15 | Алькон Инк. | Силикон-гидрогелевые контактные линзы |
MY197057A (en) | 2017-06-07 | 2023-05-23 | Alcon Inc | Method for producing silicone hydrogel contact lenses |
CN110621483B (zh) | 2017-06-07 | 2021-10-29 | 爱尔康公司 | 硅氧烷水凝胶隐形眼镜 |
WO2019116139A1 (en) | 2017-12-13 | 2019-06-20 | Novartis Ag | Weekly and monthly disposable water gradient contact lenses |
TWI662064B (zh) * | 2018-05-22 | 2019-06-11 | 國立交通大學 | 雙性高分子、雙性高分子製造方法、包含此雙性高分子的隱形眼鏡材料以及隱形眼鏡製造方法 |
DE102018127812B4 (de) * | 2018-11-07 | 2020-06-18 | Fachhochschule Kiel | Kontaktlinse mit einer Oberflächenbeschichtung und Herstellungsverfahren |
US20200385532A1 (en) * | 2019-06-06 | 2020-12-10 | Apexlens Co., Ltd. | Hydrophilic and oxygen permeable polymer material |
CN113101010A (zh) * | 2021-04-14 | 2021-07-13 | 广州宏达医疗设备有限公司 | 一种角膜基质内人工角膜及其制备方法 |
US11945966B2 (en) * | 2021-12-09 | 2024-04-02 | Canon Kabushiki Kaisha | Photocurable composition with enhanced thermal stability |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5734518A (en) * | 1980-08-01 | 1982-02-24 | Ei Peiman Gooramu | Soft contact lens with intimately crosslinked polymer coating, lens in eye and method of producing same |
EP0657751A2 (en) | 1993-12-10 | 1995-06-14 | Menicon Co., Ltd. | Soft ocular lens material |
JPH07191286A (ja) * | 1993-11-16 | 1995-07-28 | Ciba Geigy Ag | 非含水型軟質コンタクトレンズおよびその製造方法 |
US5556929A (en) * | 1993-09-27 | 1996-09-17 | Menicon Co., Ltd. | Ocular lens material |
JPH10319207A (ja) * | 1997-05-16 | 1998-12-04 | Hoya Corp | 両面同時成膜方法および装置 |
JPH11326849A (ja) * | 1998-05-20 | 1999-11-26 | Toray Ind Inc | 眼用レンズ用ポリマーの製造法 |
EP1136521A2 (en) | 2000-03-21 | 2001-09-26 | Menicon Co., Ltd. | Ocular lens material having hydrophilic surface and process for preparing the same |
EP1197782A1 (en) | 2000-03-22 | 2002-04-17 | Menicon Co., Ltd. | Material for ocular lens |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2152064B (en) * | 1983-12-27 | 1986-12-03 | Toyo Contact Lens Co Ltd | Water-absorptive contact lenses |
JPH06214197A (ja) * | 1993-01-18 | 1994-08-05 | Seiko Epson Corp | ソフトコンタクトレンズ |
JP3234359B2 (ja) * | 1993-07-16 | 2001-12-04 | 株式会社メニコン | 着色されたコンタクトレンズの製法 |
JP4547806B2 (ja) * | 1998-08-14 | 2010-09-22 | 日油株式会社 | ポリシロキサン−ポリアミド共重合体、その製造方法及び各種材料 |
US6630243B2 (en) * | 1999-05-20 | 2003-10-07 | Bausch & Lomb Incorporated | Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating |
US6200626B1 (en) * | 1999-05-20 | 2001-03-13 | Bausch & Lomb Incorporated | Surface-treatment of silicone medical devices comprising an intermediate carbon coating and graft polymerization |
DE19928888A1 (de) * | 1999-06-24 | 2001-01-11 | Schott Glas | Ophthalmische Linse sowie Verfahren zu deren Herstellung |
US6770728B2 (en) * | 1999-06-30 | 2004-08-03 | Menicon Co., Ltd. | Process for preparing ocular lens with urethane compound and process for preparing urethane compound for medical instruments |
ES2328009T5 (es) * | 1999-12-16 | 2013-12-12 | Coopervision International Holding Company, Lp | Lente de contacto blanda con capacidad de ser utilizada a largo plazo |
US6774178B2 (en) * | 2001-01-05 | 2004-08-10 | Novartis Ag | Tinted, high Dk ophthalmic molding and a method for making same |
WO2003048220A2 (en) * | 2001-11-30 | 2003-06-12 | E. I. Du Pont De Nemours And Company | Graft copolymers of methylene lactones and process for emulsion polymerization of methylene lactones |
JP4045135B2 (ja) * | 2002-07-03 | 2008-02-13 | 株式会社メニコン | 含水性コンタクトレンズ及びその製造方法 |
-
2004
- 2004-01-08 CN CNB2004800019977A patent/CN100529842C/zh not_active Expired - Lifetime
- 2004-01-08 US US10/541,746 patent/US8124668B2/en not_active Expired - Fee Related
- 2004-01-08 JP JP2005507976A patent/JP4235204B2/ja not_active Expired - Lifetime
- 2004-01-08 WO PCT/JP2004/000071 patent/WO2004063795A1/ja active Application Filing
- 2004-01-08 EP EP10152506.1A patent/EP2180366B1/en not_active Expired - Lifetime
- 2004-01-08 DE DE602004032420T patent/DE602004032420D1/de not_active Expired - Lifetime
- 2004-01-08 AT AT04700780T patent/ATE507501T1/de not_active IP Right Cessation
- 2004-01-08 EP EP04700780A patent/EP1582910B1/en not_active Expired - Lifetime
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5734518A (en) * | 1980-08-01 | 1982-02-24 | Ei Peiman Gooramu | Soft contact lens with intimately crosslinked polymer coating, lens in eye and method of producing same |
US5556929A (en) * | 1993-09-27 | 1996-09-17 | Menicon Co., Ltd. | Ocular lens material |
JPH07191286A (ja) * | 1993-11-16 | 1995-07-28 | Ciba Geigy Ag | 非含水型軟質コンタクトレンズおよびその製造方法 |
EP0657751A2 (en) | 1993-12-10 | 1995-06-14 | Menicon Co., Ltd. | Soft ocular lens material |
JPH10319207A (ja) * | 1997-05-16 | 1998-12-04 | Hoya Corp | 両面同時成膜方法および装置 |
JPH11326849A (ja) * | 1998-05-20 | 1999-11-26 | Toray Ind Inc | 眼用レンズ用ポリマーの製造法 |
EP1136521A2 (en) | 2000-03-21 | 2001-09-26 | Menicon Co., Ltd. | Ocular lens material having hydrophilic surface and process for preparing the same |
EP1197782A1 (en) | 2000-03-22 | 2002-04-17 | Menicon Co., Ltd. | Material for ocular lens |
Cited By (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008511870A (ja) * | 2004-08-27 | 2008-04-17 | 旭化成アイミー株式会社 | シリコーンヒドロゲルコンタクトレンズ |
JP2013008055A (ja) * | 2004-08-27 | 2013-01-10 | Coopervision Internatl Holding Co Lp | シリコーンヒドロゲルコンタクトレンズ |
KR101210417B1 (ko) | 2005-09-05 | 2012-12-10 | 호야 가부시키가이샤 | 콘택트렌즈 재료의 제조 방법 및 소프트 콘택트렌즈의 제조방법 |
JP2014089477A (ja) * | 2006-06-15 | 2014-05-15 | Coopervision Internatl Holding Co Lp | 湿潤性シリコーンヒドロゲルコンタクトレンズ及び関連組成物及び方法 |
US7540609B2 (en) * | 2006-06-15 | 2009-06-02 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US8552085B2 (en) | 2006-06-15 | 2013-10-08 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US9804417B2 (en) | 2006-06-15 | 2017-10-31 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US8231218B2 (en) | 2006-06-15 | 2012-07-31 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
JP2009014977A (ja) * | 2007-07-04 | 2009-01-22 | Seed Co Ltd | 含水性眼用レンズ |
JP2010097225A (ja) * | 2007-10-04 | 2010-04-30 | Menicon Co Ltd | 眼用レンズ用着色剤、眼用レンズ用材料、眼用レンズの製造方法および眼用レンズ |
JPWO2009044853A1 (ja) * | 2007-10-04 | 2011-02-10 | 株式会社メニコン | 眼用レンズ用着色剤、眼用レンズ用材料、眼用レンズの製造方法および眼用レンズ |
JP4495780B2 (ja) * | 2007-10-04 | 2010-07-07 | 株式会社メニコン | 眼用レンズ用着色剤、眼用レンズ用材料、眼用レンズの製造方法および眼用レンズ |
WO2009044853A1 (ja) * | 2007-10-04 | 2009-04-09 | Menicon Co., Ltd. | 眼用レンズ用着色剤、眼用レンズ用材料、眼用レンズの製造方法および眼用レンズ |
JP5564949B2 (ja) * | 2007-11-13 | 2014-08-06 | 東亞合成株式会社 | 硬化型組成物 |
JP2013163819A (ja) * | 2007-11-13 | 2013-08-22 | Toagosei Co Ltd | ウレタン(メタ)アクリレートの製造方法 |
WO2009099164A1 (ja) | 2008-02-08 | 2009-08-13 | Asahi Kasei Aime Co., Ltd. | 親水性ポリシロキサンマクロモノマー、その製造および用途 |
JP2012513042A (ja) * | 2008-12-18 | 2012-06-07 | ノバルティス アーゲー | シリコーンハイドロゲルコンタクトレンズの製造方法 |
JP2014238609A (ja) * | 2008-12-18 | 2014-12-18 | ノバルティス アーゲー | シリコーンハイドロゲルコンタクトレンズの製造方法 |
JP2013504682A (ja) * | 2009-09-15 | 2013-02-07 | ノバルティス アーゲー | 紫外線吸収性コンタクトレンズの製造に適したプレポリマー |
KR101585290B1 (ko) * | 2009-09-15 | 2016-01-13 | 노파르티스 아게 | 자외선 흡수성 콘택트 렌즈를 제조하는데 적합한 예비중합체 |
JP2011219512A (ja) * | 2010-04-02 | 2011-11-04 | Menicon Co Ltd | 重合性組成物、ポリマー材料、眼用レンズ及びコンタクトレンズ |
JP2018106189A (ja) * | 2010-07-30 | 2018-07-05 | ノバルティス アーゲー | 架橋親水性コーティングを備えるシリコーンヒドロゲルレンズ |
JP2013540188A (ja) * | 2010-10-06 | 2013-10-31 | ノバルティス アーゲー | ダングリング親水性ポリマー鎖を有する連鎖延長ポリシロキサン架橋剤 |
WO2012057096A1 (ja) | 2010-10-25 | 2012-05-03 | 株式会社メニコン | アゾ色素、眼用レンズ材料、眼用レンズ材料の製造方法及び眼用レンズ |
WO2013024880A1 (ja) * | 2011-08-17 | 2013-02-21 | 東レ株式会社 | 低含水性軟質眼用レンズおよびその製造方法 |
US9753187B2 (en) | 2011-08-17 | 2017-09-05 | Toray Industries, Inc. | Low hydrous soft ophthalmic lens and method for manufacturing the same |
JP2015508425A (ja) * | 2011-12-14 | 2015-03-19 | センプラス・バイオサイエンシーズ・コーポレイションSemprus Biosciences Corp. | 表面改質したコンタクトレンズ |
JP2016511841A (ja) * | 2013-02-12 | 2016-04-21 | 康夫 松澤 | シリコーンコンタクトレンズ及びその製造方法 |
CN103406973B (zh) * | 2013-07-25 | 2015-08-05 | 中南大学 | 一种醇水基料浆凝胶注模制备多孔或致密材料的成型工艺 |
CN103406973A (zh) * | 2013-07-25 | 2013-11-27 | 中南大学 | 一种醇水基料浆凝胶注模制备多孔或致密材料的成型工艺 |
WO2015092858A1 (ja) * | 2013-12-16 | 2015-06-25 | 株式会社メニコン | 眼用レンズ用ポリシロキサン系マクロモノマー及びそれを用いた眼用レンズ |
WO2015092859A1 (ja) * | 2013-12-16 | 2015-06-25 | 株式会社メニコン | 眼用レンズ |
US9650473B2 (en) | 2013-12-16 | 2017-05-16 | Menicon Co., Ltd. | Polysiloxane-based macromonomer for ophthalmic lens and ophthalmic lens using the same |
US9657131B2 (en) | 2013-12-16 | 2017-05-23 | Menicon Co., Ltd. | Ophthalmic lens |
JP6023899B2 (ja) * | 2013-12-16 | 2016-11-09 | 株式会社メニコン | 眼用レンズ |
JP2015230341A (ja) * | 2014-06-03 | 2015-12-21 | 株式会社メニコン | コンタクトレンズおよびその製造方法 |
JP2015230342A (ja) * | 2014-06-03 | 2015-12-21 | 株式会社メニコン | コンタクトレンズおよびその製造方法 |
WO2015186634A1 (ja) * | 2014-06-03 | 2015-12-10 | 株式会社 メニコン | コンタクトレンズおよびその製造方法 |
WO2015186620A1 (ja) * | 2014-06-03 | 2015-12-10 | 株式会社 メニコン | コンタクトレンズおよびその製造方法 |
US10183452B2 (en) | 2014-06-03 | 2019-01-22 | Menicon Co., Ltd. | Contact lens and process for producing same |
US10221273B2 (en) | 2014-06-03 | 2019-03-05 | Menicon Co., Ltd. | Contact lens and process for producing same |
JP2016133593A (ja) * | 2015-01-19 | 2016-07-25 | 株式会社メニコン | コンタクトレンズの製造方法 |
US11782294B2 (en) | 2015-09-15 | 2023-10-10 | Largan Medical Co., Ltd. | Multifocal contact lens and contact lens product |
US10845622B2 (en) | 2015-09-15 | 2020-11-24 | Largan Medical Co., Ltd. | Multifocal contact lens and contact lens product |
RU2748735C2 (ru) * | 2016-08-05 | 2021-05-31 | Джонсон Энд Джонсон Вижн Кэа, Инк. | Полимерные композиции, содержащие привитые полимерные сетки, и способы их получения и применения |
US11021558B2 (en) | 2016-08-05 | 2021-06-01 | Johnson & Johnson Vision Care, Inc. | Polymer compositions containing grafted polymeric networks and processes for their preparation and use |
US11820850B2 (en) | 2016-08-05 | 2023-11-21 | Johnson & Johnson Vision Care, Inc. | Polymer compositions containing grafted polymeric networks and processes for their preparation and use |
JP2018045232A (ja) * | 2016-09-02 | 2018-03-22 | 星歐光學股▲ふん▼有限公司 | コンタクトレンズ製品 |
US10961341B2 (en) | 2018-01-30 | 2021-03-30 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use |
US11780953B2 (en) | 2018-01-30 | 2023-10-10 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices containing localized grafted networks and processes for their preparation and use |
US11034789B2 (en) | 2018-01-30 | 2021-06-15 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices containing localized grafted networks and processes for their preparation and use |
US11834547B2 (en) | 2018-01-30 | 2023-12-05 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use |
WO2022224717A1 (ja) * | 2021-04-19 | 2022-10-27 | 国立研究開発法人物質・材料研究機構 | 軟質眼用レンズ及びその製造方法 |
US11912800B2 (en) | 2021-09-29 | 2024-02-27 | Johnson & Johnson Vision Care, Inc. | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses |
Also Published As
Publication number | Publication date |
---|---|
JP4235204B2 (ja) | 2009-03-11 |
US20060142410A1 (en) | 2006-06-29 |
EP1582910B1 (en) | 2011-04-27 |
EP2180366B1 (en) | 2013-09-25 |
DE602004032420D1 (de) | 2011-06-09 |
CN100529842C (zh) | 2009-08-19 |
US8124668B2 (en) | 2012-02-28 |
JPWO2004063795A1 (ja) | 2006-05-18 |
EP2180366A1 (en) | 2010-04-28 |
EP1582910A4 (en) | 2006-05-31 |
CN1723411A (zh) | 2006-01-18 |
EP1582910A1 (en) | 2005-10-05 |
ATE507501T1 (de) | 2011-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4235204B2 (ja) | 安全性の高いシリコーン含有眼用レンズ材料およびその製造方法 | |
JP3850729B2 (ja) | 眼用レンズ材料 | |
JP2774233B2 (ja) | 眼用レンズ材料 | |
JP3195662B2 (ja) | 眼用レンズ材料 | |
JP5897906B2 (ja) | 高分子アントラキノン系色素、これを用いた眼用レンズ材料及び眼用レンズ | |
JP5766603B2 (ja) | 眼用レンズ | |
JP6836503B2 (ja) | ゲル、ゲルの製造方法、レンズ、コンタクトレンズ表面改質剤、重合性組成物及び重合体 | |
JP2011219512A (ja) | 重合性組成物、ポリマー材料、眼用レンズ及びコンタクトレンズ | |
JP2014040598A (ja) | ポリマー材料、眼用レンズ及びコンタクトレンズ | |
JP3108550B2 (ja) | 軟質眼用レンズ材料 | |
JP6023899B2 (ja) | 眼用レンズ | |
JPH11286521A (ja) | 眼用レンズ材料 | |
WO2015092858A1 (ja) | 眼用レンズ用ポリシロキサン系マクロモノマー及びそれを用いた眼用レンズ | |
JP5302981B2 (ja) | 親水性表面を有する眼用レンズおよび眼用レンズの製造方法 | |
TWI822963B (zh) | 聚合物材料及眼科用醫療器械 | |
JP6974633B2 (ja) | ポリマー材料 | |
JP4502638B2 (ja) | コンタクトレンズ材料 | |
JPH10148797A (ja) | 眼用レンズ材料 | |
JPH09189887A (ja) | 眼用レンズ材料 | |
JP2010111880A (ja) | コンタクトレンズ材料の製造方法 | |
JPH09297285A (ja) | 眼用レンズおよびその製法 | |
JPH1180274A (ja) | 光学材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005507976 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2006142410 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004700780 Country of ref document: EP Ref document number: 10541746 Country of ref document: US Ref document number: 20048019977 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004700780 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10541746 Country of ref document: US |